Gary S. Gillheeney insider trades

Open-market stock purchases and sales by Gary S. Gillheeney, President and CEO at Organogenesis Holdings Inc, from SEC Form 4 filings since Dec 10, 2018.

Recent trades

DateStockTradeValue
Feb 18, 2026ORGO Organogenesis Holdings IncBought (not open market)—
Feb 18, 2026ORGO Organogenesis Holdings IncSold (not open market)$351K
Feb 18, 2026ORGO Organogenesis Holdings IncBought (not open market)—
Feb 18, 2026ORGO Organogenesis Holdings IncBought (not open market)—
Feb 18, 2026ORGO Organogenesis Holdings IncSold (not open market)$347K
Feb 18, 2026ORGO Organogenesis Holdings IncBought (not open market)—
Feb 15, 2026ORGO Organogenesis Holdings IncSold (not open market)$90.8K
Feb 15, 2026ORGO Organogenesis Holdings IncSold (not open market)$293K
Feb 15, 2026ORGO Organogenesis Holdings IncSold (not open market)$309K
Feb 15, 2026ORGO Organogenesis Holdings IncSold (not open market)$319K

Companies traded

  • ORGO Organogenesis Holdings Inc: 34 sales, last Feb 18, 2026

Get free alerts when Gary S. Gillheeney files a new trade →